Press "esc" to clear
Go to Advanced Search

Showing results

110 of 224
photo_4.jpg

Article ID: 694730

Ebola Virus - Subject Matter Experts at Georgetown

Georgetown University Medical Center

Released:
17-May-2018 8:55 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
hemo-virus-vaccine-large.jpg

Article ID: 694538

Vaccine-Induced Antibodies Against One Hemorrhagic Fever Virus Found to Disarm Related Virus for Which There Is No Vaccine

Harvard Medical School

Research conducted in vitro shows two human antibodies made in response to vaccination against one hemorrhagic fever virus can disarm a related virus, for which there is currently no vaccine. The proof-of-principle finding identifies a common molecular chink in the two viruses’ armor that renders both vulnerable to the same antibodies. The results set the stage for a single vaccine and other antibody-based treatments that work against multiple viral “cousins” despite key differences in their genetic makeup. Such therapies can alleviate challenges posed by current lack of vaccines and prevent outbreaks of viral hemorrhagic fevers.

Released:
14-May-2018 2:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Ebola.jpg

Article ID: 694529

Mapping the Body’s Battle with Ebola and Zika

Los Alamos National Laboratory

The viruses that cause Ebola and Zika, daunting diseases that inspire concern at every outbreak, share a strong similarity in how they first infiltrate a host’s cells.

Released:
14-May-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
bsquare-300x300.jpg

Article ID: 691734

Researchers Identify Chemical Compound That Inhibits Ebola Virus Replication

Georgia State University

An organic chemical compound shows effective antiviral activity against Ebola virus and several other viruses, according to a study led by Georgia State University.

Released:
26-Mar-2018 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
GGH_6168.JPG
  • Embargo expired:
    22-Feb-2018 9:30 AM EST

Article ID: 689866

Promising Treatment for Ebola Virus to be Tested at Texas Biomed

Texas Biomedical Research Institute

During the West African Ebola outbreak that began in 2013, an experimental biopharmaceutical drug called ZMappTM was a glimmer of hope in the midst of a health crisis. Now, scientists at Texas Biomedical Research Institute in San Antonio have been awarded a $2 million dollar contract by the makers of ZMapp, Mapp Biopharmaceutical, Inc., to further test this promising new therapeutic.

Released:
20-Feb-2018 4:15 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
andersen_kristian.jpg

Article ID: 689655

TSRI Scientists Receive $15 Million to Study Viral Outbreak Survivors

Scripps Research Institute

The researchers will spend the next five years collecting data from Ebola and Lassa survivors to learn how they fought off the virus.

Released:
15-Feb-2018 5:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Marburg_structure.jpg
  • Embargo expired:
    10-Jan-2018 12:00 PM EST

Article ID: 687718

TSRI Scientists Discover Workings of First Promising Marburg Virus Treatment

Scripps Research Institute

Scientists at The Scripps Research Institute have discovered the workings of the first promising treatment for Marburg virus, a pathogen with the same pandemic potential as Ebola virus.

Released:
9-Jan-2018 5:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Ebolavirusresearcher-NicoleHoff.jpg

Article ID: 686837

40 Years After First Ebola Outbreak, Survivors Show Signs They Can Stave Off New Infection

University of California, Los Angeles (UCLA), Health Sciences

Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks

Released:
14-Dec-2017 12:05 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Kawaoka-Sierra-Leone-8.jpg

Article ID: 685385

Unlocking the Secrets of Ebola

Pacific Northwest National Laboratory

Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease. The results come from one of the most in-depth studies ever of blood samples from patients with Ebola.

Released:
16-Nov-2017 4:05 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Ebolavial.JPG
  • Embargo expired:
    16-Nov-2017 12:00 PM EST

Article ID: 685218

In the Heart of Devastating Outbreak, Research Team Unlocks Secrets of Ebola

University of Wisconsin-Madison

In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin–Madison has identified signatures of Ebola virus disease that may aid in future treatment efforts.

Released:
14-Nov-2017 4:30 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 224





Chat now!